Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Non-Current Assets (2016 - 2025)

Neuroone Medical Technologies' Non-Current Assets history spans 9 years, with the latest figure at $510525.0 for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 34.77% year-over-year to $510525.0; the TTM value through Dec 2025 reached $2.4 million, down 20.2%, while the annual FY2025 figure was $559363.0, 24.31% down from the prior year.
  • Non-Current Assets reached $510525.0 in Q4 2025 per NMTC's latest filing, down from $559363.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $879353.0 in Q2 2023 to a low of $510525.0 in Q4 2025.
  • Average Non-Current Assets over 5 years is $683912.2, with a median of $666946.0 recorded in 2024.
  • Peak YoY movement for Non-Current Assets: soared 37.04% in 2023, then crashed 34.77% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $607928.0 in 2021, then rose by 14.03% to $693233.0 in 2022, then increased by 5.21% to $729371.0 in 2023, then increased by 7.31% to $782665.0 in 2024, then plummeted by 34.77% to $510525.0 in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Non-Current Assets are $510525.0 (Q4 2025), $559363.0 (Q3 2025), and $648734.0 (Q2 2025).